In fact, one year later, the same group designed a flow-through lab-on-chip device that took advantage of the surface-bound aptamer’s affinity for EGFR, the biomarker overexpressed in GBM, to demonstrate that a microfluidic-based approach can be used to detect and isolate GBM cells [31]. The gene discussed is EGFR; the disease is glioblastoma.